The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.

<h4>Purpose</h4>Metastatic neuroendocrine tumors secrete serotonin and other vasoactive substances that are responsible for carcinoid syndrome and carcinoid heart disease. We sought to evaluate the discriminatory utility of diagnostic biomarkers in determining the presence and severity o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rebecca Dobson, Malcolm I Burgess, Melissa Banks, D Mark Pritchard, Jiten Vora, Juan W Valle, Christopher Wong, Carrie Chadwick, Keith George, Brian Keevil, Joanne Adaway, Joy E S Ardill, Alan Anthoney, Uschi Hofmann, Graeme J Poston, Daniel J Cuthbertson
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5217811fa4b24bbab6c22b18b2408990
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5217811fa4b24bbab6c22b18b2408990
record_format dspace
spelling oai:doaj.org-article:5217811fa4b24bbab6c22b18b24089902021-11-18T08:55:33ZThe association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.1932-620310.1371/journal.pone.0073679https://doaj.org/article/5217811fa4b24bbab6c22b18b24089902013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24069222/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Purpose</h4>Metastatic neuroendocrine tumors secrete serotonin and other vasoactive substances that are responsible for carcinoid syndrome and carcinoid heart disease. We sought to evaluate the discriminatory utility of diagnostic biomarkers in determining the presence and severity of carcinoid heart disease in patients with metastatic neuroendocrine tumors.<h4>Patients and methods</h4>A cross-sectional study of patients with neuroendocrine tumors with documented liver metastases and/or carcinoid syndrome between April 2009-October 2012 in 5 tertiary referral centers. Serum was analyzed for Chromogranin A, Chromogranin B and N-terminal pro Brain Natriuretic Peptide (NT-proBNP). Plasma was analyzed for Neurokinin A and 5-Hydroxyindoleacetic acid (5HIAA). Echocardiography was used to determine the presence and severity of carcinoid heart disease. Non-parametric receiver operating characteristic curves were constructed for biomarkers, and the area under the curve determined. The severity of cardiac involvement was correlated with the concentration of each biomarker.<h4>Results</h4>A total of 187 patients were identified of whom 37 (20%) had carcinoid heart disease. Significantly higher median values of all biomarkers were found in the patients with cardiac involvement. NT-proBNP and plasma 5HIAA had the highest areas under the curve for the prediction of carcinoid heart disease [NT-proBNP 0.82 (95% confidence interval 0.74-0.90, p<0.0001) and 5HIAA 0.85 (95% confidence interval 0.78-0.92, p<0.0001]. NT-proBNP was moderately correlated (r = 0.48, p<0.001) whereas plasma 5HIAA was only weakly correlated (r = 0.34, p<0.001) with the echocardiographic severity score.<h4>Conclusion</h4>NT-proBNP and plasma 5HIAA are both sensitive and specific biomarkers for the presence of carcinoid heart disease whereas only NT-proBNP is moderately correlated with disease severity.Rebecca DobsonMalcolm I BurgessMelissa BanksD Mark PritchardJiten VoraJuan W ValleChristopher WongCarrie ChadwickKeith GeorgeBrian KeevilJoanne AdawayJoy E S ArdillAlan AnthoneyUschi HofmannGraeme J PostonDaniel J CuthbertsonPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e73679 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Rebecca Dobson
Malcolm I Burgess
Melissa Banks
D Mark Pritchard
Jiten Vora
Juan W Valle
Christopher Wong
Carrie Chadwick
Keith George
Brian Keevil
Joanne Adaway
Joy E S Ardill
Alan Anthoney
Uschi Hofmann
Graeme J Poston
Daniel J Cuthbertson
The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.
description <h4>Purpose</h4>Metastatic neuroendocrine tumors secrete serotonin and other vasoactive substances that are responsible for carcinoid syndrome and carcinoid heart disease. We sought to evaluate the discriminatory utility of diagnostic biomarkers in determining the presence and severity of carcinoid heart disease in patients with metastatic neuroendocrine tumors.<h4>Patients and methods</h4>A cross-sectional study of patients with neuroendocrine tumors with documented liver metastases and/or carcinoid syndrome between April 2009-October 2012 in 5 tertiary referral centers. Serum was analyzed for Chromogranin A, Chromogranin B and N-terminal pro Brain Natriuretic Peptide (NT-proBNP). Plasma was analyzed for Neurokinin A and 5-Hydroxyindoleacetic acid (5HIAA). Echocardiography was used to determine the presence and severity of carcinoid heart disease. Non-parametric receiver operating characteristic curves were constructed for biomarkers, and the area under the curve determined. The severity of cardiac involvement was correlated with the concentration of each biomarker.<h4>Results</h4>A total of 187 patients were identified of whom 37 (20%) had carcinoid heart disease. Significantly higher median values of all biomarkers were found in the patients with cardiac involvement. NT-proBNP and plasma 5HIAA had the highest areas under the curve for the prediction of carcinoid heart disease [NT-proBNP 0.82 (95% confidence interval 0.74-0.90, p<0.0001) and 5HIAA 0.85 (95% confidence interval 0.78-0.92, p<0.0001]. NT-proBNP was moderately correlated (r = 0.48, p<0.001) whereas plasma 5HIAA was only weakly correlated (r = 0.34, p<0.001) with the echocardiographic severity score.<h4>Conclusion</h4>NT-proBNP and plasma 5HIAA are both sensitive and specific biomarkers for the presence of carcinoid heart disease whereas only NT-proBNP is moderately correlated with disease severity.
format article
author Rebecca Dobson
Malcolm I Burgess
Melissa Banks
D Mark Pritchard
Jiten Vora
Juan W Valle
Christopher Wong
Carrie Chadwick
Keith George
Brian Keevil
Joanne Adaway
Joy E S Ardill
Alan Anthoney
Uschi Hofmann
Graeme J Poston
Daniel J Cuthbertson
author_facet Rebecca Dobson
Malcolm I Burgess
Melissa Banks
D Mark Pritchard
Jiten Vora
Juan W Valle
Christopher Wong
Carrie Chadwick
Keith George
Brian Keevil
Joanne Adaway
Joy E S Ardill
Alan Anthoney
Uschi Hofmann
Graeme J Poston
Daniel J Cuthbertson
author_sort Rebecca Dobson
title The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.
title_short The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.
title_full The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.
title_fullStr The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.
title_full_unstemmed The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.
title_sort association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/5217811fa4b24bbab6c22b18b2408990
work_keys_str_mv AT rebeccadobson theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT malcolmiburgess theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT melissabanks theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT dmarkpritchard theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT jitenvora theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT juanwvalle theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT christopherwong theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT carriechadwick theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT keithgeorge theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT briankeevil theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT joanneadaway theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT joyesardill theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT alananthoney theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT uschihofmann theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT graemejposton theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT danieljcuthbertson theassociationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT rebeccadobson associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT malcolmiburgess associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT melissabanks associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT dmarkpritchard associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT jitenvora associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT juanwvalle associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT christopherwong associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT carriechadwick associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT keithgeorge associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT briankeevil associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT joanneadaway associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT joyesardill associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT alananthoney associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT uschihofmann associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT graemejposton associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
AT danieljcuthbertson associationofapanelofbiomarkerswiththepresenceandseverityofcarcinoidheartdiseaseacrosssectionalstudy
_version_ 1718421140543635456